Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) treatment metyrosine (ONO-5371), a tyrosine hydroxylase inhibitor licensed fr 30 April 2018
After previously dashed hopes for a proposed ’right to try’ bill were resurrected in late March, the legislative process has reportedly now ground to a halt, leaving supporters of the concept, including the White House, with few options. 27 April 2018
Shares in US-based Acadia have fallen sharply on news that the US Food and Drug Administration is reviewing its Parkinson’s drug Nuplazid (pimavanserin). 27 April 2018
Neurocrine Biosciences has presented a new analysis of data from the KINECT 3 Phase III trial of Ingrezza (valbenazine) showing improved outcomes for tardive dyskinesia (TD) patients. 26 April 2018
The China-Denmark drug regulatory thematic seminar was held in Beijing earlier this month, the China Food and Drug Administration announced today. 23 April 2018
Privately-held Swiss drugmaker Helsinn said today that the US Food and Drug Administration has approved the intravenous formulation of Akynzeo (fosnetupitant/palonosetron) as an alternative treatment option for patients experiencing chemotherapy-induced nausea and vomiting (CINV). 20 April 2018
Eisai says that the bile acid transporter inhibitor Goofice 5mg tablet (elobixibat hydrate) was listed in Japan’s National Health Insurance Drug Price List as of April 18, 2018, and Eisai subsidiary EA Pharma and Mochida Pharmaceutical launched the product onto Japan’s market yesterday. 20 April 2018
Amazon Business, which sells bulk items to business customers, has shelved its plan to sell and distribute pharmaceutical products after considering it last year, according to people familiar with the matter, report Eugene Kim and Christina Farr on CNBC. 17 April 2018
MilliporeSigma today announced a partnership with Oxford University's Jenner Institute to develop more robust and scalable vaccine manufacturing processes. 12 April 2018
Cannabis giant GW Pharmaceuticals and US subsidiary Greenwich Biosciences will present data from the Phase III trials of Epidiolex in rare neuropsychiatric disorders at the American Academy of Neurology annual meeting in California. 12 April 2018
Verona Pharma, a London-based firm specializing in the treatment of respiratory diseases, has announced the resignation of its chief medical officer effective April 30. 11 April 2018
Italian drugmaker Recordati has completed an agreement with Mylan for the acquisition of the rights to Cystagon (cysteamine bitartrate), indicated for the treatment of proven nephropathic cystinosis in children and adults, for certain territories, including Europe. 9 April 2018
California’s Aradigm says the European Medicines Agency is to proceed with reviewing the firm’s application to market Linhaliq (ciprofloxacin liposomal) as a treatment for certain non-cystic fibrosis bronchiectasis (NCFBE) patients. 6 April 2018
In a meeting closed to media and unconfirmed by the Japanese drugmaker, Takeda CEO Christopher Weber told analysts “size was no obstacle for any ‘mindful’ acquisition,” Reuters reports. 6 April 2018
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Gan & Lee Pharmaceuticals as reported that its three investigational drugs - GZR18, GZR4, and GZR101 - achieved positive results in Phase II diabetes trials. 17 October 2024
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024